Pierrel Research International AG, announces that we will be attending the Partnerships in Clinical Trials Conference that will be held in Lyons, France on November 15-18, 2011.
Zurich, September 19, 2011 – Pierrel Research International AG representatives from several of the 20 international offices will be there to represent specialty offerings of Pierrel Research.
Michael Laird, the CEO of Pierrel Research USA, Inc., a wholly owned subsidiary
of Pierrel Research International AG, commented that “[t]his meeting has always
been a great opportunity to discuss clinical research in a global setting. It is well
attended by both North American clinical and outsourcing decision makers and
provides an excellent forum for discussing challenges in multinational research.”
Luigi Visani, M.D., the CEO of Pierrel Research International AG is pleased with
the company’s focus on emphasizing clinical trial work in the European markets.
“Pierrel is particularly skilled at ensuring that our customers are well represented
in Europe. In the past few years, there has been added emphasis on the quality
of clinical research in these markets and Pierrel Research has done a fantastic
job in helping its clients understand the local and global implications of
international research.”
Dr. Visani also discussed Pierrel Research’s newly formed relationship with Dr.
Regenold, GmbH and emphasized how this alliance will strengthen sponsor
relationships. “Partnering with this very qualified international regulatory
company and the regulanet® network” will enable us to provide global regulatory
services and obtain strategic input at the early stage of a clinical development
program for new drugs and devices. Pierrel can assist its clients in preventing
future delays in their drug development programs by correctly interpreting
regulations and guidelines, developing a strategy for all technical aspects of drug
development (from quality to preclinical and clinical), designing and managing a
complete registration program (from phase I through final dossier preparation
and submission), and assessing market access requirements during the early
stage of development.
About Pierrel Research International AG:
Pierrel Research International AG is a global contract research organization which operates both in Europe and the USA, providing consultancies and full services for research and development of new molecules, drug products, and devices. It is a wholly owned subsidiary of Pierrel S.p.A. Pierrel S.p.A., a global provider to the pharmaceutical and life science industries, specializes in Research and development (Contract
Research) and production (Contract Manufacturing) of drug products, and is listed on the Italian Stock Exchange. The Pierrel Group enjoys more than 50 years of experience in the pharmaceutical sector and is one of the main European manufacturers of dental anesthetic drug products. The manufacturing facility in Capua, Italy, near Naples, has been authorized by the FDA for the production of sterile small volumes parenteral drugs.
Pierrel Research USA, Inc. is located in Wayne, Pennsylvania.
For further information:
Business Development
Gary Goldberg at g.goldberg@pierrelgroup.com
Tel. 610-975-9533
Pierrel S.p.A Corporate office is located in Milan, Italy. For further information:
Pierrel S.p.A.
Investor Relations
Dott. Aurelio Matrone
Email: investor.relations@pierrelgroup.com
tel. +39 02 2413491 fax +39 02 24134201
Image Building
Simona Raffaelli, Emanuela Borromeo, Camilla Castaldo
Tel. 02/8901.1300
E-mail: pierrel@imagebuilding.it